Recent Domain News

Mike Zapolin’s PrescriptionDrugs.com Website Earns Spot in Harvard Business School Contest

Michael “Zappy” Zapolin has scored a major honor for his latest category killing domain name development project – PrescriptionDrugs.com. The Harvard Business School has selected the site as a candidate in their “New Ventures” competition. Zappy will present to a panel of judges this month with a spot in the final 3 on the line.

Read More

Is Google Profiting Unfairly From Typosquatters? (Fast Company Magazine)

A Harvard professor has made it his personal crusade to tell the world how the search giant makes buckets of duckets off people who register deceptive Web addresses. A slightly more refined variant of cybersquatting, typosquatting involves purchasing domains that are one character away from popular Web sites and serve up ads (or malware) to clumsy typists who land there by mistake. As the Web’s …

Read More

Google Makes $500m a Year on Typos (Slashdot)

holy_calamity writes “New Scientist reports on an analysis by Harvard researchers that suggests Google rakes in half a billion dollars annually from advertising that appears on typosquatting domains. They estimate that 60 per cent of typosquatting pages use Google ads, but the advertising giant declined to discuss whether it should be working with such pages.” Read more of this story at Slashdot.

Read More

Measuring Typosquatting Perpetrators and Funders (CircleID)

Co-authored by Tyler Moore , at Harvard School of Engineering and Applied Sciences and Benjamin Edelman , at Harvard Business School. For more than a decade, aggressive website registrants have been engaged in ‘typosquatting’—the intentional registration of misspellings of popular website addresses.

Read More

DN Journal Releases Latest Quarterly Analysis of Sales Trends in the Domain Aftermarket

DN Journal’s latest monthly newsletter breaks down 3Q-2008 domain sales to see what the numbers reveal about the health of the aftermarket. Plus, more info and photos from Kevin Ham and Chris Hartnett’s adventures at Harvard Business School.

Read More